Last reviewed · How we verify
Estrogen Receptor Antagonist
Estrogen Receptor Antagonist is a Small molecule drug developed by BeOne Medicines. It is currently in Phase 1 development.
At a glance
| Generic name | Estrogen Receptor Antagonist |
|---|---|
| Sponsor | BeOne Medicines |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Menopausal Hormones and Sympathetic Activation (PHASE4)
- ORION-1: Study of AVZO-023 as a Single Agent and in Combination With AVZO-021, and/or Endocrine Therapy in Advanced Solid Tumors (PHASE1, PHASE2)
- Preoperative Window Opportunity Study With Giredestrant or Tamoxifen in Premenopausal Women With ER+/HER2[-] & Ki67≥10% (PHASE2)
- An Investigational Study of BG-75202 Alone and in Combination With Other Therapeutic Agents in Adults With Advanced Solid Tumors (PHASE1)
- Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors (PHASE1, PHASE2)
- Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer (PHASE3)
- Estrogen to Improve Quality of Life for Men With Newly Diagnosed or Recurrent Metastatic Hormone Sensitive Prostate Cancer, EQUIP Trial (PHASE2)
- Prototype DAA/TAA Vaccine Targeting MUC1 for Immune Interception and Prevention in Ductal Carcinoma In Situ (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Estrogen Receptor Antagonist CI brief — competitive landscape report
- Estrogen Receptor Antagonist updates RSS · CI watch RSS
- BeOne Medicines portfolio CI
Frequently asked questions about Estrogen Receptor Antagonist
What is Estrogen Receptor Antagonist?
Estrogen Receptor Antagonist is a Small molecule drug developed by BeOne Medicines.
Who makes Estrogen Receptor Antagonist?
Estrogen Receptor Antagonist is developed by BeOne Medicines (see full BeOne Medicines pipeline at /company/beone-medicines).
What development phase is Estrogen Receptor Antagonist in?
Estrogen Receptor Antagonist is in Phase 1.
Related
- Manufacturer: BeOne Medicines — full pipeline
- Compare: Estrogen Receptor Antagonist vs similar drugs
- Pricing: Estrogen Receptor Antagonist cost, discount & access